This inventor holds 1 USPTO granted patent. Top assignee: The University of Queensland. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: John Abbenante: Innovator in HIV Protease Inhibitors
Introduction
John Abbenante is a notable inventor based in Chelmer, Australia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV protease inhibitors. His work has the potential to impact the treatment of HIV, showcasing his dedication to advancing medical science.
Latest Patents
John Abbenante holds 1 patent related to HIV protease inhibitors. This patent represents a crucial step in the ongoing battle against HIV, providing new avenues for treatment and management of the virus.
Career Highlights
Abbenante is affiliated with The University of Queensland, where he continues to engage in research and development. His role at the university allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Doug Bergman and Ross Brinkworth. Their collective expertise enhances the research environment and fosters innovation in their projects.
Conclusion
John Abbenante's work in HIV protease inhibitors exemplifies the impact of dedicated inventors in the medical field. His contributions are vital in the fight against HIV, and his ongoing research promises to yield further advancements in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile